{
  "specifications": {
    "obo:GENEPIO_0001007": {
      "definition": "The NCBI antibiogram standard details the reporting specifications for antimicrobial susceptibility and resistance data derived from drug resistant pathogens. This information is submitted as an antibiogram table on BioSample records.",
      "part_of": [
        "obo:FOODON_03000003"
      ],
      "parts": {
        "obo:GENEPIO_0002056": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:OBI_0001614": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0001100": [
          {
            "cardinality": "owl:someValuesFrom"
          }
        ],
        "obo:OBI_0001616": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:qualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0002049": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0002045": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0002062": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0002047": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:maxQualifiedCardinality",
            "value": "1"
          }
        ]
      },
      "parent": "obo:GENEPIO_0000115",
      "datatype": "specification",
      "id": "obo:GENEPIO_0001007",
      "uiLabel": "NCBI Antibiogram standard"
    },
    "obo:GENEPIO_0002056": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001008",
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001007"
      ],
      "id": "obo:GENEPIO_0002056",
      "uiLabel": "lab typing platform vendor"
    },
    "obo:OBI_0001614": {
      "definition": "A CRID symbol uniquely indentifies the submitted GeneBank sequence record.",
      "part_of": [
        "obo:GENEPIO_0001007",
        "obo:GENEPIO_0001008"
      ],
      "datatype": "xmls:string",
      "uiLabel": "GenBank ID",
      "id": "obo:OBI_0001614",
      "constraints": [
        {
          "datatype": "xmls:nonNegativeInteger",
          "value": "1",
          "constraint": "owl:qualifiedCardinality"
        }
      ]
    },
    "obo:GENEPIO_0001100": {
      "part_of": [
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001007"
      ],
      "parts": {
        "obo:GENEPIO_0002044": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:qualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0002037": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:qualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:CHEBI_22582": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:qualifiedCardinality",
            "value": "1"
          }
        ],
        "obo:GENEPIO_0001001": [
          {
            "datatype": "xmls:nonNegativeInteger",
            "cardinality": "owl:qualifiedCardinality",
            "value": "1"
          }
        ]
      },
      "parent": "obo:GENEPIO_0001611",
      "datatype": "specification",
      "id": "obo:GENEPIO_0001100",
      "uiLabel": "NCBI Antibiogram drug test model"
    },
    "obo:GENEPIO_0002044": {
      "units": [
        "obo:UO_0000016",
        "obo:UO_0000274"
      ],
      "part_of": [
        "obo:GENEPIO_0001100",
        "obo:GENEPIO_0001008"
      ],
      "definition": "The antibiotic test dosage is the amount of antibiotic delivered to the isolate plate or well.",
      "datatype": "xmls:float",
      "uiLabel": "antibiotic test dosage",
      "id": "obo:GENEPIO_0002044",
      "constraints": [
        {
          "datatype": "xmls:nonNegativeInteger",
          "value": "1",
          "constraint": "owl:qualifiedCardinality"
        }
      ]
    },
    "obo:GENEPIO_0002037": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001100",
        "obo:GENEPIO_0001008"
      ],
      "id": "obo:GENEPIO_0002037",
      "uiLabel": "antibiotic resistance phenotype"
    },
    "obo:CHEBI_22582": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001008",
        "obo:GENEPIO_0001100"
      ],
      "id": "obo:CHEBI_22582",
      "uiLabel": "antibiotic"
    },
    "obo:GENEPIO_0001001": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001100",
        "obo:GENEPIO_0001008"
      ],
      "id": "obo:GENEPIO_0001001",
      "uiLabel": "measurement threshold comparison"
    },
    "obo:OBI_0001616": {
      "definition": "A CRID symbol denotes a specimen and used to distinguish one specimen from another in an investigation.",
      "part_of": [
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001621",
        "obo:GENEPIO_0001650",
        "obo:GENEPIO_0000015",
        "obo:GENEPIO_0000111",
        "obo:GENEPIO_0001073",
        "obo:GENEPIO_0001835",
        "obo:GENEPIO_0001007",
        "obo:GENEPIO_0002000",
        "obo:GENEPIO_0001581",
        "obo:GENEPIO_0001008"
      ],
      "hasSynonym": [
        "sample identifier"
      ],
      "datatype": "xmls:string",
      "uiLabel": "specimen identifier",
      "id": "obo:OBI_0001616",
      "constraints": [
        {
          "datatype": "xmls:nonNegativeInteger",
          "value": "1",
          "constraint": "owl:qualifiedCardinality"
        }
      ]
    },
    "obo:GENEPIO_0002049": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001007",
        "obo:GENEPIO_0001008"
      ],
      "id": "obo:GENEPIO_0002049",
      "uiLabel": "lab typing platform"
    },
    "obo:GENEPIO_0002045": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001007",
        "obo:GENEPIO_0001008"
      ],
      "id": "obo:GENEPIO_0002045",
      "uiLabel": "antibiotic lab typing method"
    },
    "obo:GENEPIO_0002062": {
      "datatype": "xmls:anyURI",
      "definition": "These are agency-defined standard reference methods for testing (includes quality control parameters and criteria for interpreting results)",
      "part_of": [
        "obo:GENEPIO_0001008",
        "obo:GENEPIO_0001099",
        "obo:GENEPIO_0001007"
      ],
      "id": "obo:GENEPIO_0002062",
      "uiLabel": "antimicrobial resistance testing standard"
    },
    "obo:GENEPIO_0002047": {
      "datatype": "xmls:anyURI",
      "part_of": [
        "obo:GENEPIO_0001008",
        "obo:GENEPIO_0001007",
        "obo:GENEPIO_0001099"
      ],
      "id": "obo:GENEPIO_0002047",
      "uiLabel": "antibiotic lab typing method version or reagent"
    }
  },
  "picklists": {
    "obo:GENEPIO_0002056": {
      "uiLabel": "lab typing platform vendor",
      "id": "obo:GENEPIO_0002056",
      "members": {
        "obo:GENEPIO_0002059": [],
        "obo:GENEPIO_0002058": [],
        "obo:GENEPIO_0002057": [],
        "obo:GENEPIO_0002054": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:GENEPIO_0002059": {
      "uiLabel": "Becton Dickinson",
      "id": "obo:GENEPIO_0002059",
      "member_of": [
        "obo:GENEPIO_0002056"
      ]
    },
    "obo:GENEPIO_0002058": {
      "uiLabel": "Biom√©rieux",
      "id": "obo:GENEPIO_0002058",
      "member_of": [
        "obo:GENEPIO_0002056"
      ]
    },
    "obo:GENEPIO_0002057": {
      "uiLabel": "Siemens",
      "id": "obo:GENEPIO_0002057",
      "member_of": [
        "obo:GENEPIO_0002056"
      ]
    },
    "obo:GENEPIO_0002054": {
      "uiLabel": "Trek",
      "id": "obo:GENEPIO_0002054",
      "member_of": [
        "obo:GENEPIO_0002056"
      ]
    },
    "obo:GENEPIO_0002037": {
      "uiLabel": "antibiotic resistance phenotype",
      "id": "obo:GENEPIO_0002037",
      "members": {
        "obo:GENEPIO_0002038": [],
        "obo:GENEPIO_0002039": [],
        "obo:GENEPIO_0002040": [],
        "obo:GENEPIO_0002041": [],
        "obo:GENEPIO_0002042": [],
        "obo:GENEPIO_0002043": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:GENEPIO_0002038": {
      "definition": "Intermediate resistance indicates that an isolate is observed to offer an intermediate level of resistance to a given antibiotic.",
      "hasSynonym": [
        "sensitive"
      ],
      "member_of": [
        "obo:GENEPIO_0002037"
      ],
      "uiLabel": "antibiotic intermediate resistance",
      "id": "obo:GENEPIO_0002038"
    },
    "obo:GENEPIO_0002039": {
      "definition": "non-susceptible indicates that an isolate is observed to offer complete resistance to a given antibiotic.",
      "uiLabel": "antibiotic nonsusceptible (high resistance)",
      "id": "obo:GENEPIO_0002039",
      "member_of": [
        "obo:GENEPIO_0002037"
      ]
    },
    "obo:GENEPIO_0002040": {
      "definition": "A not defined resistance indicates that an isolate was not tested against a given antibiotic, or the result of the test was inconclusive.",
      "uiLabel": "antibiotic resistance not defined",
      "id": "obo:GENEPIO_0002040",
      "member_of": [
        "obo:GENEPIO_0002037"
      ]
    },
    "obo:GENEPIO_0002041": {
      "definition": "Resistant indicates that an isolate is observed to offer a greater than intermediate level of resistance to a given antibiotic.",
      "uiLabel": "antibiotic resistant",
      "id": "obo:GENEPIO_0002041",
      "member_of": [
        "obo:GENEPIO_0002037"
      ]
    },
    "obo:GENEPIO_0002042": {
      "definition": "Susceptible indicates that an isolate is observed to offer a detectable but less than intermediate level of resistance to a given antibiotic.",
      "uiLabel": "antibiotic susceptible (low resistance)",
      "id": "obo:GENEPIO_0002042",
      "member_of": [
        "obo:GENEPIO_0002037"
      ]
    },
    "obo:GENEPIO_0002043": {
      "definition": "Susceptible - dose dependent indicates that an isolate is observed to offer resistance to a given antibiotic when a sufficient dose is given.",
      "uiLabel": "antibiotic susceptible - dose dependent",
      "id": "obo:GENEPIO_0002043",
      "member_of": [
        "obo:GENEPIO_0002037"
      ]
    },
    "obo:CHEBI_22582": {
      "uiLabel": "antibiotic",
      "id": "obo:CHEBI_22582",
      "members": {
        "obo:CHEBI_36420": [],
        "obo:CHEBI_86478": [],
        "obo:CHEBI_2790": [],
        "obo:CHEBI_68452": [],
        "obo:CHEBI_27933": [],
        "obo:CHEBI_60584": [],
        "obo:CHEBI_46633": [],
        "obo:CHEBI_124991": [],
        "obo:CHEBI_209807": [],
        "obo:CHEBI_29007": [],
        "obo:CHEBI_23066": [],
        "obo:CHEBI_3716": [],
        "obo:CHEBI_3907": [],
        "obo:CHEBI_4885": [],
        "obo:CHEBI_87211": [],
        "obo:CHEBI_5195": [],
        "obo:CHEBI_24531": [],
        "obo:CHEBI_63607": [],
        "obo:CHEBI_281056": [],
        "obo:CHEBI_599928": [],
        "obo:CHEBI_63611": [],
        "obo:CHEBI_7025": [],
        "obo:CHEBI_17154": [],
        "obo:CHEBI_87230": [],
        "obo:CHEBI_71415": [],
        "obo:CHEBI_28368": [],
        "obo:CHEBI_7731": [],
        "obo:CHEBI_35991": [],
        "obo:CHEBI_17334": [],
        "obo:CHEBI_26144": [],
        "obo:CHEBI_9997": [],
        "obo:CHEBI_17939": [],
        "obo:CHEBI_39447": [],
        "obo:CHEBI_46770": [],
        "obo:CHEBI_26513": [],
        "obo:CHEBI_86324": [],
        "obo:CHEBI_29673": [],
        "obo:CHEBI_75246": [],
        "obo:CHEBI_9215": [],
        "obo:CHEBI_9321": [],
        "obo:CHEBI_63845": [],
        "obo:CHEBI_87228": [],
        "obo:CHEBI_9421": [],
        "obo:CHEBI_9587": [],
        "obo:GENEPIO_0002072": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:CHEBI_36420": {
      "definition": "A polycyclic heteroarene that is anthracene in which one of the central CH groups is replaced by a nitrogen atom.",
      "uiLabel": "acridine",
      "id": "obo:CHEBI_36420",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_86478": {
      "definition": "Heteroorganic entities that are microbial metabolites (or compounds derived from them) which have significant antifungal properties.",
      "uiLabel": "antibiotic antifungal agent",
      "id": "obo:CHEBI_86478",
      "members": {
        "obo:CHEBI_87113": [],
        "obo:CHEBI_87114": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_87113": {
      "definition": "Any antibiotic antifungal agent used to treat fungal infections in humans or animals.",
      "uiLabel": "antibiotic antifungal drug",
      "id": "obo:CHEBI_87113",
      "members": {
        "obo:CHEBI_17076": []
      },
      "member_of": [
        "obo:CHEBI_86478"
      ]
    },
    "obo:CHEBI_17076": {
      "definition": "A amino cyclitol glycoside that consists of streptidine having a disaccharyl moiety attached at the 4-position. The parent of the streptomycin class",
      "uiLabel": "streptomycin",
      "id": "obo:CHEBI_17076",
      "member_of": [
        "obo:CHEBI_87113",
        "obo:CHEBI_87114"
      ]
    },
    "obo:CHEBI_87114": {
      "definition": "Any antibiotic antifungal agent that has been used as a fungicide.",
      "uiLabel": "antibiotic fungicide",
      "id": "obo:CHEBI_87114",
      "members": {
        "obo:CHEBI_17076": []
      },
      "member_of": [
        "obo:CHEBI_86478"
      ]
    },
    "obo:CHEBI_2790": {
      "definition": "An aminoglycoside that is 2-deoxystreptamine that is substituted on the oxygen at position 4 by an (8R)-2-amino-8-O-(4-amino-4-deoxy-alpha-D-glucopyranosyl)-2,3,7-trideoxy-7-(methylamino)-D-glycero-alpha-D-allo-octodialdo-1,5:8,4-dipyranos-1-yl) group.",
      "uiLabel": "apramycin",
      "id": "obo:CHEBI_2790",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_68452": {
      "definition": "Any monocyclic heteroarene consisting of a five-membered ring containing nitrogen. Azoles can also contain one or more other non-carbon atoms, such as nitrogen, sulfur or oxygen.",
      "uiLabel": "azole",
      "id": "obo:CHEBI_68452",
      "members": {
        "obo:CHEBI_23677": [],
        "obo:CHEBI_35790": [],
        "obo:CHEBI_26455": [],
        "obo:CHEBI_35689": [],
        "obo:CHEBI_48901": [],
        "obo:CHEBI_35727": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_23677": {
      "definition": "An azole that is either one of a pair of heterocyclic organic compounds comprising three carbon atoms and two nitrogen atoms arranged in a ring.",
      "uiLabel": "diazole",
      "id": "obo:CHEBI_23677",
      "members": {
        "obo:CHEBI_24780": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_24780": {
      "definition": "A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton.",
      "uiLabel": "imidazoles",
      "id": "obo:CHEBI_24780",
      "members": {
        "obo:CHEBI_6909": [],
        "obo:CHEBI_63627": []
      },
      "member_of": [
        "obo:CHEBI_23677"
      ]
    },
    "obo:CHEBI_6909": {
      "definition": "A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.",
      "uiLabel": "metronidazole",
      "id": "obo:CHEBI_6909",
      "member_of": [
        "obo:CHEBI_24780"
      ]
    },
    "obo:CHEBI_63627": {
      "definition": "1H-imidazole substituted at C-1 by a (2-ethylsulfonyl)ethyl group, at C-2 by a methyl group and at C-5 by a nitro group.  It is used as an antiprotozoal, antibacterial agent.",
      "uiLabel": "tinidazole",
      "id": "obo:CHEBI_63627",
      "member_of": [
        "obo:CHEBI_24780"
      ]
    },
    "obo:CHEBI_35790": {
      "definition": "An azole based on a five-membered heterocyclic aromatic skeleton containing one N and one O atom.",
      "uiLabel": "oxazole",
      "id": "obo:CHEBI_35790",
      "members": {
        "obo:CHEBI_46812": [],
        "obo:CHEBI_55373": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_46812": {
      "uiLabel": "1,3-oxazoles",
      "id": "obo:CHEBI_46812",
      "members": {
        "obo:CHEBI_9997": []
      },
      "member_of": [
        "obo:CHEBI_35790"
      ]
    },
    "obo:CHEBI_9997": {
      "definition": "A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.",
      "uiLabel": "pristinamycin IIA",
      "id": "obo:CHEBI_9997",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_46812"
      ]
    },
    "obo:CHEBI_55373": {
      "definition": "Oxazoles in which the N and O atoms are adjacent.",
      "uiLabel": "isoxazoles",
      "id": "obo:CHEBI_55373",
      "members": {
        "obo:CHEBI_9332": [],
        "obo:CHEBI_102484": []
      },
      "member_of": [
        "obo:CHEBI_35790"
      ]
    },
    "obo:CHEBI_9332": {
      "definition": "An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.",
      "uiLabel": "sulfamethoxazole",
      "id": "obo:CHEBI_9332",
      "member_of": [
        "obo:CHEBI_55373",
        "obo:CHEBI_87228"
      ]
    },
    "obo:CHEBI_102484": {
      "definition": "A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.",
      "uiLabel": "sulfisoxazole",
      "id": "obo:CHEBI_102484",
      "member_of": [
        "obo:CHEBI_55373",
        "obo:CHEBI_87228"
      ]
    },
    "obo:CHEBI_26455": {
      "definition": "An azole that includes only one N atom and no other heteroatom as a part of the aromatic skeleton.",
      "uiLabel": "pyrroles",
      "id": "obo:CHEBI_26455",
      "members": {
        "obo:CHEBI_3907": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_3907": {
      "definition": "A hydroxycoumarin antibiotic that is obtained from Streptomyces rishiriensis and exhibits potent antibacterial and anticancer activity.",
      "uiLabel": "coumermycin A1",
      "id": "obo:CHEBI_3907",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_26455"
      ]
    },
    "obo:CHEBI_35689": {
      "definition": "An azole in which the five-membered heterocyclic aromatic skeleton contains four N atoms and one C atom.",
      "uiLabel": "tetrazoles",
      "id": "obo:CHEBI_35689",
      "members": {
        "obo:CHEBI_474053": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_474053": {
      "definition": "A cephalosporin compound having [(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl and (1H-tetrazol-1-ylacetyl)amino side-groups.",
      "uiLabel": "cefazolin",
      "id": "obo:CHEBI_474053",
      "member_of": [
        "obo:CHEBI_23066",
        "obo:CHEBI_35689"
      ]
    },
    "obo:CHEBI_48901": {
      "definition": "An azole in which the five-membered heterocyclic aromatic skeleton contains a N atom and one S atom.",
      "uiLabel": "thiazoles",
      "id": "obo:CHEBI_48901",
      "members": {
        "obo:CHEBI_38418": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_38418": {
      "uiLabel": "1,3-thiazole",
      "id": "obo:CHEBI_38418",
      "members": {
        "obo:CHEBI_204928": [],
        "obo:CHEBI_70718": [],
        "obo:CHEBI_29007": []
      },
      "member_of": [
        "obo:CHEBI_48901"
      ]
    },
    "obo:CHEBI_204928": {
      "definition": "A cephalosporin compound having acetoxymethyl and [2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino side groups.",
      "uiLabel": "cefotaxime",
      "id": "obo:CHEBI_204928",
      "member_of": [
        "obo:CHEBI_23066",
        "obo:CHEBI_38418"
      ]
    },
    "obo:CHEBI_70718": {
      "definition": "A cephalosporin that is the N-phospho prodrug of ceftaroline. A broad-spectrum antibiotic, it is active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections.",
      "uiLabel": "ceftaroline fosamil",
      "id": "obo:CHEBI_70718",
      "member_of": [
        "obo:CHEBI_23066",
        "obo:CHEBI_38418"
      ]
    },
    "obo:CHEBI_29007": {
      "definition": "A cephalosporin compound having 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetylamino and [(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl side-groups.",
      "uiLabel": "ceftriaxone",
      "id": "obo:CHEBI_29007",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_23066",
        "obo:CHEBI_38418"
      ]
    },
    "obo:CHEBI_35727": {
      "definition": "An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms.",
      "uiLabel": "triazoles",
      "id": "obo:CHEBI_35727",
      "members": {
        "obo:CHEBI_9421": []
      },
      "member_of": [
        "obo:CHEBI_68452"
      ]
    },
    "obo:CHEBI_9421": {
      "definition": "A member of the class of penicillanic acids that is sulbactam in which one of the exocyclic methyl hydrogens is replaced by a 1,2,3-triazol-1-yl group; used (in the form of its sodium salt) in combination with ceftolozane sulfate for treatment of complicated intra-abdominal infections and complicated urinary tract infections.",
      "uiLabel": "tazobactam",
      "id": "obo:CHEBI_9421",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25865",
        "obo:CHEBI_35727"
      ]
    },
    "obo:CHEBI_27933": {
      "definition": "An organonitrogen heterocyclic antibiotic that contains a beta-lactam ring.",
      "uiLabel": "beta-lactam antibiotic",
      "id": "obo:CHEBI_27933",
      "members": {
        "obo:CHEBI_55504": [],
        "obo:CHEBI_46633": [],
        "obo:CHEBI_38311": [],
        "obo:CHEBI_50695": [],
        "obo:CHEBI_55506": [],
        "obo:CHEBI_35992": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25558"
      ]
    },
    "obo:CHEBI_55504": {
      "definition": "Any member of a group of synthetic antibiotics, similar to cephems but with carbon substituted for the sulfur; all possessing an acylated amine functionality at C-6 and (S,R) stereochemistry at C-6 and C-7.",
      "uiLabel": "carbacephem",
      "id": "obo:CHEBI_55504",
      "members": {
        "obo:CHEBI_281056": []
      },
      "member_of": [
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_281056": {
      "definition": "The conjugate base of loracarbef.",
      "uiLabel": "loracarbef anion",
      "id": "obo:CHEBI_281056",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_55504"
      ]
    },
    "obo:CHEBI_46633": {
      "definition": "The class of beta-lactam antibiotics that whose members have a carbapenem skeleton which is variously substituted at positions 3, 4, and 6.",
      "uiLabel": "carbapenems",
      "id": "obo:CHEBI_46633",
      "members": {
        "obo:CHEBI_46634": [],
        "obo:CHEBI_471744": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_46634": {
      "uiLabel": "carbapenemcarboxylic acid",
      "id": "obo:CHEBI_46634",
      "members": {
        "obo:CHEBI_404903": [],
        "obo:CHEBI_43968": []
      },
      "member_of": [
        "obo:CHEBI_46633"
      ]
    },
    "obo:CHEBI_404903": {
      "definition": "Meropenem in which the one of the two methyl groups attached to the amide nitrogen is replaced by hydrogen while the other is replaced by a 3-carboxyphenyl group. The sodium salt is used for the treatment of moderate to severe susceptible infections including intra-abdominal  and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract.",
      "uiLabel": "ertapenem",
      "id": "obo:CHEBI_404903",
      "member_of": [
        "obo:CHEBI_46634",
        "obo:CHEBI_46770"
      ]
    },
    "obo:CHEBI_43968": {
      "uiLabel": "meropenem",
      "id": "obo:CHEBI_43968",
      "member_of": [
        "obo:CHEBI_46634",
        "obo:CHEBI_46770"
      ]
    },
    "obo:CHEBI_471744": {
      "definition": "A broad-spectrum, intravenous beta-lactam antibiotic of the carbapenem subgroup.",
      "uiLabel": "imipenem",
      "id": "obo:CHEBI_471744",
      "member_of": [
        "obo:CHEBI_46633"
      ]
    },
    "obo:CHEBI_38311": {
      "uiLabel": "cephem",
      "id": "obo:CHEBI_38311",
      "members": {
        "obo:CHEBI_23066": [],
        "obo:CHEBI_55429": []
      },
      "member_of": [
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_23066": {
      "definition": "A class of beta-lactam antibiotics differing from the penicillins in having a 6-membered, rather than a 5-membered, side ring.  Although cephalosporins are among the most commonly used antibiotics in the treatment of routine infections, and their use is increasing over time, they can cause a range of hypersensitivity reactions, from mild, delayed-onset cutaneous reactions to life-threatening anaphylaxis in patients with immunoglobulin E (IgE)-mediated allergy.",
      "uiLabel": "cephalosporin",
      "id": "obo:CHEBI_23066",
      "members": {
        "obo:CHEBI_3478": [],
        "obo:CHEBI_3479": [],
        "obo:CHEBI_124991": [],
        "obo:CHEBI_3480": [],
        "obo:CHEBI_474053": [],
        "obo:CHEBI_3485": [],
        "obo:CHEBI_59343": [],
        "obo:CHEBI_478164": [],
        "obo:CHEBI_472657": [],
        "obo:CHEBI_3489": [],
        "obo:CHEBI_3491": [],
        "obo:CHEBI_3493": [],
        "obo:CHEBI_204928": [],
        "obo:CHEBI_355510": [],
        "obo:CHEBI_209807": [],
        "obo:CHEBI_3504": [],
        "obo:CHEBI_3506": [],
        "obo:CHEBI_70718": [],
        "obo:CHEBI_3508": [],
        "obo:CHEBI_3510": [],
        "obo:CHEBI_553473": [],
        "obo:CHEBI_29007": [],
        "obo:CHEBI_3534": [],
        "obo:CHEBI_554446": [],
        "obo:CHEBI_3547": [],
        "obo:CHEBI_599928": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_38311"
      ]
    },
    "obo:CHEBI_3478": {
      "definition": "A cephalosporin bearing chloro and (R)-2-amino-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",
      "uiLabel": "cefaclor",
      "id": "obo:CHEBI_3478",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3479": {
      "definition": "A cephalosporin bearing methyl and  (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",
      "uiLabel": "cefadroxil",
      "id": "obo:CHEBI_3479",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_124991": {
      "definition": "A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.",
      "uiLabel": "cefalotin",
      "id": "obo:CHEBI_124991",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3480": {
      "definition": "A cephalosporin compound having (R)-mandelamido and N-methylthiotetrazole side-groups.",
      "uiLabel": "cefamandole",
      "id": "obo:CHEBI_3480",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3485": {
      "definition": "A cephalosporin compound having 7beta-2-(2-amino-thiazol-4-yl)-2-[(Z)-hydroxyimino]-acetylamino- and 3-vinyl side groups.",
      "uiLabel": "cefdinir",
      "id": "obo:CHEBI_3485",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_59343": {
      "definition": "A broad spectrum, third-generation cephalosporin antibiotic with (Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. Generally administered as its orally absorbed pivaloyloxymethyl ester prodrug, it is used for the treatment of mild to moderate infections caused by susceptible strains of microorganisms in acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, pharyngitis/tonsillitis, and uncomplicated skin and skin-structure infections.",
      "uiLabel": "cefditoren",
      "id": "obo:CHEBI_59343",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_478164": {
      "definition": "A cephalosporin bearing (1-methylpyrrolidinium-1-yl)methyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",
      "uiLabel": "cefepime",
      "id": "obo:CHEBI_478164",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_472657": {
      "definition": "A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.",
      "uiLabel": "cefixime",
      "id": "obo:CHEBI_472657",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3489": {
      "definition": "A cephalosporin antibiotic containg an N(1)-methyltetrazol-5-ylthiomethyl side-chain at C-3 of the parent cephem bicyclic structure.",
      "uiLabel": "cefmetazole",
      "id": "obo:CHEBI_3489",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3491": {
      "definition": "A cephalosporin bearing {[1-(sulfomethyl)-1H-tetrazol-5-yl]sulfanyl}methyl and (R)-2-hydroxy-2-phenylacetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",
      "uiLabel": "cefonicid",
      "id": "obo:CHEBI_3491",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3493": {
      "definition": "A semi-synthetic parenteral cephalosporin with a tetrazolyl moiety that confers beta-lactamase resistance.",
      "uiLabel": "cefoperazone",
      "id": "obo:CHEBI_3493",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_355510": {
      "definition": "A cephalosporin with ({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl and (2-amino-1,3-thiazol-4-yl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. A third generation beta-lactam cephalosporin antibiotic, it is active against a broad spectrum of both Gram positive and Gram negative bacteria.",
      "uiLabel": "cefotiam",
      "id": "obo:CHEBI_355510",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_209807": {
      "definition": "A semisynthetic cephamycin antibiotic which, in addition to the methoxy group at the 7alpha position, has 2-thienylacetamido and carbamoyloxymethyl side-groups. It is resistant to beta-lactamase.",
      "uiLabel": "cefoxitin",
      "id": "obo:CHEBI_209807",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_23066",
        "obo:CHEBI_55429"
      ]
    },
    "obo:CHEBI_3504": {
      "definition": "A third-generation cephalosporin antibiotic with methoxymethyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamino substituents at positions 3 and 7, respectively, of the cephem skeleton. Given by mouth as its proxetil ester prodrug, it is used to treat acute otitis media, pharyngitis, and sinusitis.",
      "uiLabel": "cefpodoxime",
      "id": "obo:CHEBI_3504",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3506": {
      "definition": "A semisynthetic, second-generation cephalosporin, with prop-1-enyl and (R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used to treat bronchitis as well as ear, skin and other bacterial infections.",
      "uiLabel": "cefprozil",
      "id": "obo:CHEBI_3506",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3508": {
      "definition": "A cephalosporin bearing pyridinium-1-ylmethyl and {[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetamido groups at positions 3 and 7, respectively, of the cephem skeleton.",
      "uiLabel": "ceftazidime",
      "id": "obo:CHEBI_3508",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3510": {
      "definition": "A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to treat urinary-tract and respiratory-tract infections.",
      "uiLabel": "ceftibuten",
      "id": "obo:CHEBI_3510",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_553473": {
      "definition": "A parenteral third-generation cephalosporin, bearing a 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino group at the 7beta-position.",
      "uiLabel": "ceftizoxime",
      "id": "obo:CHEBI_553473",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3534": {
      "definition": "A semisynthetic first-generation cephalosporin antibiotic having methyl and beta-(2R)-2-amino-2-phenylacetamido groups at the 3- and 7- of the cephem skeleton, respectively. It is effective against both Gram-negative and Gram-positive organisms, and is used for treatment of infections of the skin, respiratory tract and urinary tract.",
      "uiLabel": "cephalexin",
      "id": "obo:CHEBI_3534",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_554446": {
      "definition": "A cephalosporin with  acetoxymethyl and 2(pyridin-4-ylsulfanyl)acetamido substituents at positions 3 and 7, respectively, of the cephem skeleton. It is used (as its sodium salt) as an antibiotic, being effective against gram-negative and gram-positive organisms.",
      "uiLabel": "cephapirin",
      "id": "obo:CHEBI_554446",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_3547": {
      "definition": "A cephalosporin with a methyl substituent at position 3, and a (2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetamido substituent at position 7, of the cephem skeleton.",
      "uiLabel": "cephradine",
      "id": "obo:CHEBI_3547",
      "member_of": [
        "obo:CHEBI_23066"
      ]
    },
    "obo:CHEBI_599928": {
      "definition": "A broad-spectrum oxacephem antibiotic in which the oxazine ring is substituted with a tetrazolylthiomethyl group and the azetidinone ring carries methoxy and 2-carboxy-2-(4-hydroxyphenyl)acetamido substituents.",
      "uiLabel": "moxalactam",
      "id": "obo:CHEBI_599928",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_23066",
        "obo:CHEBI_55506"
      ]
    },
    "obo:CHEBI_55429": {
      "definition": "Any member of the cephamycin sub-group of cephem antibiotics, differing from cephalosporins in possessing a methoxy group at the 7alpha-position of the cephem nucleus, and in being resistant to beta-lactamase.",
      "uiLabel": "cephamycin",
      "id": "obo:CHEBI_55429",
      "members": {
        "obo:CHEBI_209807": []
      },
      "member_of": [
        "obo:CHEBI_38311"
      ]
    },
    "obo:CHEBI_50695": {
      "definition": "Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotic. It lacks the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.",
      "uiLabel": "monobactam",
      "id": "obo:CHEBI_50695",
      "members": {
        "obo:CHEBI_161680": []
      },
      "member_of": [
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_161680": {
      "definition": "A synthetic monocyclic beta-lactam antibiotic (monobactam).",
      "uiLabel": "aztreonam",
      "id": "obo:CHEBI_161680",
      "member_of": [
        "obo:CHEBI_50695"
      ]
    },
    "obo:CHEBI_55506": {
      "definition": "Any member of the oxacephem sub-group of cephem antibiotics, in which the thiaazabicyclo moiety of the cephalosporins is replaced by an oxaazabicyclo moiety, and  where R3 is -H or -OCH3.",
      "uiLabel": "oxacephem",
      "id": "obo:CHEBI_55506",
      "members": {
        "obo:CHEBI_599928": []
      },
      "member_of": [
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_35992": {
      "definition": "Natural and synthetic antibiotics containing the 4-thia-1-azabicyclo[3.2.0]heptan-7-one structure, generally assumed to have the 5R configuration unless otherwise specified.",
      "uiLabel": "penams",
      "id": "obo:CHEBI_35992",
      "members": {
        "obo:CHEBI_35991": [],
        "obo:CHEBI_25865": []
      },
      "member_of": [
        "obo:CHEBI_27933"
      ]
    },
    "obo:CHEBI_35991": {
      "definition": "Compound comprising a beta-lactam ring fused to a saturated 5-membered ring containing one sulfur atom.",
      "uiLabel": "penam",
      "id": "obo:CHEBI_35991",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_35992"
      ]
    },
    "obo:CHEBI_25865": {
      "uiLabel": "penicillanic acids",
      "id": "obo:CHEBI_25865",
      "members": {
        "obo:CHEBI_17334": [],
        "obo:CHEBI_9321": [],
        "obo:CHEBI_9421": []
      },
      "member_of": [
        "obo:CHEBI_35992"
      ]
    },
    "obo:CHEBI_17334": {
      "definition": "Any member of the group of substituted penams containing two methyl substituents at position 2, a carboxylate substituent at position 3 and a carboxamido group at position 6.",
      "uiLabel": "penicillin",
      "id": "obo:CHEBI_17334",
      "members": {
        "obo:CHEBI_28971": [],
        "obo:CHEBI_2956": [],
        "obo:CHEBI_3393": [],
        "obo:CHEBI_49566": [],
        "obo:CHEBI_4511": [],
        "obo:CHEBI_5098": [],
        "obo:CHEBI_18165": [],
        "obo:CHEBI_6827": [],
        "obo:CHEBI_6919": [],
        "obo:CHEBI_7447": [],
        "obo:CHEBI_18203": [],
        "obo:CHEBI_88187": [],
        "obo:CHEBI_52429": [],
        "obo:CHEBI_9587": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25865"
      ]
    },
    "obo:CHEBI_28971": {
      "definition": "A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group.",
      "uiLabel": "ampicillin",
      "id": "obo:CHEBI_28971",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_2956": {
      "definition": "A semisynthetic penicillin antibiotic used in treating infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.",
      "uiLabel": "azlocillin",
      "id": "obo:CHEBI_2956",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_3393": {
      "definition": "A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain.",
      "uiLabel": "carbenicillin",
      "id": "obo:CHEBI_3393",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_49566": {
      "definition": "A semisynthetic penicillin antibiotic carrying a 3-(2-chlorophenyl)-5-methylisoxazole-4-carboxamido group at position 6.",
      "uiLabel": "cloxacillin",
      "id": "obo:CHEBI_49566",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_4511": {
      "definition": "A penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]formyl group.",
      "uiLabel": "dicloxacillin",
      "id": "obo:CHEBI_4511",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_5098": {
      "definition": "A penicillin compound having a 6beta-[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamido] side-chain.",
      "uiLabel": "flucloxacillin",
      "id": "obo:CHEBI_5098",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_18165": {
      "uiLabel": "isopenicillin N",
      "id": "obo:CHEBI_18165",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_6827": {
      "definition": "A penicillin that is 6-aminopenicillanic acid in which one of the amino hydrogens is replaced by a 2,6-dimethoxybenzoyl group.",
      "uiLabel": "methicillin",
      "id": "obo:CHEBI_6827",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_6919": {
      "definition": "A penicillin in which the substituent at position 6 of the penam ring is a (2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido group.",
      "uiLabel": "mezlocillin",
      "id": "obo:CHEBI_6919",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_7447": {
      "uiLabel": "nafcillin",
      "id": "obo:CHEBI_7447",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_18203": {
      "uiLabel": "penicillin N",
      "id": "obo:CHEBI_18203",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_88187": {
      "definition": "Any penicillin which causes the onset of an allergic reaction.",
      "uiLabel": "penicillin allergen",
      "id": "obo:CHEBI_88187",
      "members": {
        "obo:CHEBI_2676": [],
        "obo:CHEBI_18208": [],
        "obo:CHEBI_8232": []
      },
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_2676": {
      "definition": "A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-(4-hydroxyphenyl)acetamido group.",
      "uiLabel": "amoxicillin",
      "id": "obo:CHEBI_2676",
      "member_of": [
        "obo:CHEBI_88187"
      ]
    },
    "obo:CHEBI_18208": {
      "definition": "A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group.",
      "uiLabel": "benzylpenicillin",
      "id": "obo:CHEBI_18208",
      "member_of": [
        "obo:CHEBI_88187"
      ]
    },
    "obo:CHEBI_8232": {
      "definition": "A penicillin in which the substituent at position 6 of the penam ring is a 2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido group.",
      "uiLabel": "piperacillin",
      "id": "obo:CHEBI_8232",
      "member_of": [
        "obo:CHEBI_88187"
      ]
    },
    "obo:CHEBI_52429": {
      "uiLabel": "propicillin",
      "id": "obo:CHEBI_52429",
      "member_of": [
        "obo:CHEBI_17334"
      ]
    },
    "obo:CHEBI_9587": {
      "definition": "A penicillin compound having a 6beta-[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino side-group.",
      "uiLabel": "ticarcillin",
      "id": "obo:CHEBI_9587",
      "member_of": [
        "obo:CHEBI_17334",
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_9321": {
      "uiLabel": "sulbactam",
      "id": "obo:CHEBI_9321",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25865"
      ]
    },
    "obo:CHEBI_60584": {
      "definition": "A commercially important azabicyclic antibiotic obtained from Streptomyces sapporonensis. It inhibits the Rho protein of E. coli.",
      "uiLabel": "bicozamycin",
      "id": "obo:CHEBI_60584",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_3716": {
      "definition": "A member of the class of  cinnolines  that is 6,7-methylenedioxycinnolin-4(1H)-one bearing an ethyl group at position 1 and a carboxylic acid group at position 3. An analogue of oxolinic acid, it has similar antibacterial actions. It was formerly used for the treatment of urinary tract infections.",
      "uiLabel": "cinoxacin",
      "id": "obo:CHEBI_3716",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_4885": {
      "definition": "A thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide.",
      "uiLabel": "ethionamide",
      "id": "obo:CHEBI_4885",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_87211": {
      "definition": "An organonitrogen heterocyclic antibiotic containing a quinolone (or quinolone-like) moiety and which have a fluorine atom attached to the central ring system.",
      "uiLabel": "fluoroquinolone antibiotic",
      "id": "obo:CHEBI_87211",
      "members": {
        "obo:CHEBI_5543": [],
        "obo:CHEBI_100241": [],
        "obo:CHEBI_157175": [],
        "obo:CHEBI_31810": [],
        "obo:CHEBI_116278": [],
        "obo:CHEBI_63611": [],
        "obo:CHEBI_100246": [],
        "obo:CHEBI_7731": [],
        "obo:CHEBI_50199": [],
        "obo:CHEBI_9212": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25558"
      ]
    },
    "obo:CHEBI_5543": {
      "uiLabel": "Grepafloxacin",
      "id": "obo:CHEBI_5543",
      "member_of": [
        "obo:CHEBI_26513",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_100241": {
      "definition": "A  quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.",
      "uiLabel": "ciprofloxacin",
      "id": "obo:CHEBI_100241",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_36709",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_157175": {
      "definition": "A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.",
      "uiLabel": "enoxacin",
      "id": "obo:CHEBI_157175",
      "member_of": [
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_31810": {
      "definition": "A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.",
      "uiLabel": "fleroxacin",
      "id": "obo:CHEBI_31810",
      "member_of": [
        "obo:CHEBI_26513",
        "obo:CHEBI_46845",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_116278": {
      "definition": "A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.",
      "uiLabel": "lomefloxacin",
      "id": "obo:CHEBI_116278",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_63611": {
      "definition": "A quinolone that consits of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents.",
      "uiLabel": "moxifloxacin",
      "id": "obo:CHEBI_63611",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_100246": {
      "definition": "A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.",
      "uiLabel": "norfloxacin",
      "id": "obo:CHEBI_100246",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_7731": {
      "definition": "An oxazinoquinolone carrying carboxy, fluoro, methyl and 4-methylpiperazino substituents. A synthetic fluoroquinolone antibacterial agent, it inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.",
      "uiLabel": "ofloxacin",
      "id": "obo:CHEBI_7731",
      "members": {
        "obo:CHEBI_63598": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_46845",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_63598": {
      "definition": "An optically active form of ofloxacin having (S)-configuration; an inhibitor of bacterial topoisomerase IV and DNA gyrase",
      "uiLabel": "levofloxacin",
      "id": "obo:CHEBI_63598",
      "member_of": [
        "obo:CHEBI_7731"
      ]
    },
    "obo:CHEBI_50199": {
      "definition": "A quinolone that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6 and 7 by ethyl, carboxy, fluorine, and 4-methylpiperazin-1-yl groups, respectively.",
      "uiLabel": "pefloxacin",
      "id": "obo:CHEBI_50199",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_46845",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_9212": {
      "uiLabel": "sparfloxacin",
      "id": "obo:CHEBI_9212",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324",
        "obo:CHEBI_87211"
      ]
    },
    "obo:CHEBI_5195": {
      "definition": "A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.",
      "uiLabel": "furazolidone",
      "id": "obo:CHEBI_5195",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_87230"
      ]
    },
    "obo:CHEBI_24531": {
      "uiLabel": "heterocyclic antibiotic",
      "id": "obo:CHEBI_24531",
      "members": {
        "obo:CHEBI_25558": [],
        "obo:CHEBI_25807": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_25558": {
      "uiLabel": "organonitrogen heterocyclic antibiotic",
      "id": "obo:CHEBI_25558",
      "members": {
        "obo:CHEBI_40009": [],
        "obo:CHEBI_27933": [],
        "obo:CHEBI_87211": [],
        "obo:CHEBI_87230": [],
        "obo:CHEBI_86324": []
      },
      "member_of": [
        "obo:CHEBI_24531"
      ]
    },
    "obo:CHEBI_40009": {
      "definition": "A 4-amino-1,2-oxazolidin-3-one that has R configuration. It is an antibiotic produced by Streptomyces garyphalus or S. orchidaceus and is used as part of a multi-drug regimen for the treatment of tuberculosis when resistance to, or toxicity from, primary drugs has developed. An analogue of D-alanine, it interferes with bacterial cell wall synthesis in the cytoplasm by competitive inhibition of L-alanine racemase (which forms D-alanine from L-alanine) and  D-alanine--D-alanine ligase (which incorporates D-alanine into the pentapeptide required for peptidoglycan formation and bacterial cell wall synthesis).",
      "uiLabel": "D-cycloserine",
      "id": "obo:CHEBI_40009",
      "member_of": [
        "obo:CHEBI_25558",
        "obo:CHEBI_25807"
      ]
    },
    "obo:CHEBI_87230": {
      "definition": "A member of the class of furans in which the furan ring is substituted by a nitro group and which also has significant antibiotic properties.",
      "uiLabel": "nitrofuran antibiotic",
      "id": "obo:CHEBI_87230",
      "members": {
        "obo:CHEBI_5195": [],
        "obo:CHEBI_71415": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25558",
        "obo:CHEBI_25807"
      ]
    },
    "obo:CHEBI_71415": {
      "definition": "An imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA.",
      "uiLabel": "nitrofurantoin",
      "id": "obo:CHEBI_71415",
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_87230"
      ]
    },
    "obo:CHEBI_86324": {
      "definition": "An organonitrogen heterocyclic antibiotic whose structure contains a quinolone or quinolone-related skeleton.",
      "uiLabel": "quinolone antibiotic",
      "id": "obo:CHEBI_86324",
      "members": {
        "obo:CHEBI_5543": [],
        "obo:CHEBI_100241": [],
        "obo:CHEBI_157175": [],
        "obo:CHEBI_5280": [],
        "obo:CHEBI_116278": [],
        "obo:CHEBI_63611": [],
        "obo:CHEBI_100147": [],
        "obo:CHEBI_100246": [],
        "obo:CHEBI_7731": [],
        "obo:CHEBI_50199": [],
        "obo:CHEBI_9212": []
      },
      "member_of": [
        "obo:CHEBI_22582",
        "obo:CHEBI_25558"
      ]
    },
    "obo:CHEBI_5280": {
      "definition": "A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.",
      "uiLabel": "gatifloxacin",
      "id": "obo:CHEBI_5280",
      "member_of": [
        "obo:CHEBI_23765",
        "obo:CHEBI_26512",
        "obo:CHEBI_46848",
        "obo:CHEBI_86324"
      ]
    },
    "obo:CHEBI_100147": {
      "definition": "A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively.",
      "uiLabel": "nalidixic acid",
      "id": "obo:CHEBI_100147",
      "member_of": [
        "obo:CHEBI_86324"
      ]
    },
    "obo:CHEBI_25807": {
      "uiLabel": "organooxygen heterocyclic antibiotic",
      "id": "obo:CHEBI_25807",
      "members": {
        "obo:CHEBI_40009": [],
        "obo:CHEBI_87230": []
      },
      "member_of": [
        "obo:CHEBI_24531"
      ]
    },
    "obo:CHEBI_63607": {
      "definition": "An organofluorine compound that consists of 1,3-oxazolidin-2-one bearing an N-3-fluoro-4-(morpholin-4-yl)phenyl group as well as an acetamidomethyl group at position 5. A synthetic antibacterial agent that inhibits bacterial protein synthesis by binding to a site on 23S ribosomal RNA of the 50S subunit and prevents further formation of a functional 70S initiation complex.",
      "uiLabel": "linezolid",
      "id": "obo:CHEBI_63607",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_7025": {
      "definition": "An alpha,beta-unsaturated ester resulting from the formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with the carboxy group of (2E)-4-[(2S)-tetrahydro-2H-pyran-2-yl]-3-methylbut-2-enoic acid in which the tetrahydropyranyl ring is substituted at positions 3 and 4 by hydroxy groups and at position 5 by a {(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl}methyl group. Originally isolated from the Gram-negative bacterium Pseudomonas fluorescens, it is used as a topical antibiotic for the treatment of Gram-positive bacterial infections.",
      "uiLabel": "mupirocin",
      "id": "obo:CHEBI_7025",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_17154": {
      "definition": "A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.",
      "uiLabel": "nicotinamide",
      "id": "obo:CHEBI_17154",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_28368": {
      "definition": "A coumarin-derived antibiotic obtained from Streptomyces niveus.",
      "uiLabel": "novobiocin",
      "id": "obo:CHEBI_28368",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_26144": {
      "uiLabel": "piperazines",
      "id": "obo:CHEBI_26144",
      "members": {
        "obo:CHEBI_46845": [],
        "obo:CHEBI_46848": [],
        "obo:CHEBI_46847": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_46845": {
      "uiLabel": "N-alkylpiperazine",
      "id": "obo:CHEBI_46845",
      "members": {
        "obo:CHEBI_46920": [],
        "obo:CHEBI_31810": [],
        "obo:CHEBI_7731": [],
        "obo:CHEBI_50199": []
      },
      "member_of": [
        "obo:CHEBI_26144"
      ]
    },
    "obo:CHEBI_46920": {
      "uiLabel": "N-methylpiperazine",
      "id": "obo:CHEBI_46920",
      "members": {
        "obo:CHEBI_28077": []
      },
      "member_of": [
        "obo:CHEBI_46845"
      ]
    },
    "obo:CHEBI_28077": {
      "definition": "A member of the class of rifamycins that is a a semisynthetic antibiotic derived from Amycolatopsis rifamycinica (previously known as Amycolatopsis mediterranei and Streptomyces mediterranei)",
      "uiLabel": "rifampicin",
      "id": "obo:CHEBI_28077",
      "member_of": [
        "obo:CHEBI_46847",
        "obo:CHEBI_46920"
      ]
    },
    "obo:CHEBI_46848": {
      "uiLabel": "N-arylpiperazine",
      "id": "obo:CHEBI_46848",
      "members": {
        "obo:CHEBI_100241": [],
        "obo:CHEBI_157175": [],
        "obo:CHEBI_5280": [],
        "obo:CHEBI_116278": [],
        "obo:CHEBI_100246": [],
        "obo:CHEBI_7731": [],
        "obo:CHEBI_50199": [],
        "obo:CHEBI_9212": []
      },
      "member_of": [
        "obo:CHEBI_26144"
      ]
    },
    "obo:CHEBI_46847": {
      "uiLabel": "N-iminopiperazine",
      "id": "obo:CHEBI_46847",
      "members": {
        "obo:CHEBI_28077": []
      },
      "member_of": [
        "obo:CHEBI_26144"
      ]
    },
    "obo:CHEBI_17939": {
      "definition": "An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.",
      "uiLabel": "puromycin",
      "id": "obo:CHEBI_17939",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_39447": {
      "definition": "Any compound having a pyrimidine as part of its structure.",
      "uiLabel": "pyrimidines",
      "id": "obo:CHEBI_39447",
      "members": {
        "obo:CHEBI_9328": [],
        "obo:CHEBI_9329": [],
        "obo:CHEBI_102265": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_9328": {
      "definition": "A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.",
      "uiLabel": "sulfadiazine",
      "id": "obo:CHEBI_9328",
      "member_of": [
        "obo:CHEBI_39447",
        "obo:CHEBI_87228"
      ]
    },
    "obo:CHEBI_9329": {
      "definition": "A sulfonamide consisting of pyrimidine having methoxy substituents at the 5- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. In combination with the antiprotozoal pyrimethamine (CHEBI:8673) it is used as an antimalarial.",
      "uiLabel": "sulfadoxine",
      "id": "obo:CHEBI_9329",
      "member_of": [
        "obo:CHEBI_39447"
      ]
    },
    "obo:CHEBI_102265": {
      "definition": "A sulfonamide consisting of pyrimidine with methyl substituents at the 4- and 6-positions and a 4-aminobenzenesulfonamido group at the 2-position.",
      "uiLabel": "sulfamethazine",
      "id": "obo:CHEBI_102265",
      "member_of": [
        "obo:CHEBI_39447",
        "obo:CHEBI_87228"
      ]
    },
    "obo:CHEBI_46770": {
      "uiLabel": "pyrrolidinecarboxamide",
      "id": "obo:CHEBI_46770",
      "members": {
        "obo:CHEBI_3745": [],
        "obo:CHEBI_404903": [],
        "obo:CHEBI_6472": [],
        "obo:CHEBI_43968": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_3745": {
      "definition": "A carbohydrate-containing antibiotic that is the  semisynthetic derivative of lincomycin, a natural antibiotic.",
      "uiLabel": "clindamycin",
      "id": "obo:CHEBI_3745",
      "member_of": [
        "obo:CHEBI_46770"
      ]
    },
    "obo:CHEBI_6472": {
      "definition": "A carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis.",
      "uiLabel": "lincomycin",
      "id": "obo:CHEBI_6472",
      "member_of": [
        "obo:CHEBI_46770"
      ]
    },
    "obo:CHEBI_26513": {
      "definition": "A class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.",
      "uiLabel": "quinolines",
      "id": "obo:CHEBI_26513",
      "members": {
        "obo:CHEBI_5543": [],
        "obo:CHEBI_36709": [],
        "obo:CHEBI_72292": [],
        "obo:CHEBI_31810": [],
        "obo:CHEBI_26512": [],
        "obo:CHEBI_23765": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_36709": {
      "uiLabel": "aminoquinoline",
      "id": "obo:CHEBI_36709",
      "members": {
        "obo:CHEBI_100241": []
      },
      "member_of": [
        "obo:CHEBI_26513"
      ]
    },
    "obo:CHEBI_72292": {
      "definition": "A quinoline-based antimycobacterial drug used (as its fumarate salt) for the treatment of pulmonary multi-drug resistant tuberculosis by inhibition of ATP synthase, an enzyme essential for the replication of the mycobacteria.",
      "uiLabel": "bedaquiline",
      "id": "obo:CHEBI_72292",
      "member_of": [
        "obo:CHEBI_26513"
      ]
    },
    "obo:CHEBI_26512": {
      "definition": "Any aromatic carboxylic acid that contains a quinoline moiety that is substituted by one carboxy substituent.",
      "uiLabel": "quinolinemonocarboxylic acid",
      "id": "obo:CHEBI_26512",
      "members": {
        "obo:CHEBI_100241": [],
        "obo:CHEBI_5280": [],
        "obo:CHEBI_116278": [],
        "obo:CHEBI_63611": [],
        "obo:CHEBI_100246": [],
        "obo:CHEBI_9212": []
      },
      "member_of": [
        "obo:CHEBI_26513"
      ]
    },
    "obo:CHEBI_23765": {
      "uiLabel": "quinolone",
      "id": "obo:CHEBI_23765",
      "members": {
        "obo:CHEBI_100241": [],
        "obo:CHEBI_5280": [],
        "obo:CHEBI_116278": [],
        "obo:CHEBI_63611": [],
        "obo:CHEBI_100246": [],
        "obo:CHEBI_50199": [],
        "obo:CHEBI_9212": []
      },
      "member_of": [
        "obo:CHEBI_26513"
      ]
    },
    "obo:CHEBI_29673": {
      "definition": "A member of the class of rifamycins that exhibits antibiotic and antitubercular properties.",
      "uiLabel": "rifamycin SV",
      "id": "obo:CHEBI_29673",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_75246": {
      "definition": "A semisynthetic member of the class of rifamycins and non-systemic gastrointestinal site-specific broad spectrum antibiotic. Used in the treatment of traveller's diarrhoea, hepatic encephalopathy and irritable bowel syndrome.",
      "uiLabel": "rifaximin",
      "id": "obo:CHEBI_75246",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_9215": {
      "definition": "An organic heterotricyclic antibiotic that is active against gram-negative bacteria and used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis.",
      "uiLabel": "spectinomycin",
      "id": "obo:CHEBI_9215",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_63845": {
      "definition": "A sulfonamide that is sulfanilamide acylated on the sulfonamide nitrogen.",
      "uiLabel": "sulfacetamide",
      "id": "obo:CHEBI_63845",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_87228": {
      "definition": "A class of sulfonamides whose members generally have bacteriostatic antibiotic properties.",
      "uiLabel": "sulfonamide antibiotic",
      "id": "obo:CHEBI_87228",
      "members": {
        "obo:CHEBI_9328": [],
        "obo:CHEBI_102265": [],
        "obo:CHEBI_9331": [],
        "obo:CHEBI_9332": [],
        "obo:CHEBI_102484": []
      },
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:CHEBI_9331": {
      "definition": "A sulfonamide consisting of a 1,3,4-thiadiazole nucleus with a methyl substituent at C-5 and a 4-aminobenzenesulfonamido group at C-2.",
      "uiLabel": "sulfamethizole",
      "id": "obo:CHEBI_9331",
      "member_of": [
        "obo:CHEBI_87228"
      ]
    },
    "obo:GENEPIO_0002072": {
      "uiLabel": "last resort antibiotic",
      "id": "obo:GENEPIO_0002072",
      "member_of": [
        "obo:CHEBI_22582"
      ]
    },
    "obo:GENEPIO_0001001": {
      "uiLabel": "measurement threshold comparison",
      "id": "obo:GENEPIO_0001001",
      "members": {
        "obo:GENEPIO_0001004": [],
        "obo:GENEPIO_0001006": [],
        "obo:GENEPIO_0001005": [],
        "obo:GENEPIO_0001002": [],
        "obo:GENEPIO_0001003": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:GENEPIO_0001004": {
      "definition": "The \"equal to\" comparator indicates that a given substance was present at the given quantity or concentration.",
      "member_of": [
        "obo:GENEPIO_0001001"
      ],
      "uiLabel": "==",
      "id": "obo:GENEPIO_0001004",
      "label": "equal to"
    },
    "obo:GENEPIO_0001006": {
      "definition": "The \"less than or equal to\" comparator indicates that a given substance was present at less than or equal to a given quantity or concentration.",
      "member_of": [
        "obo:GENEPIO_0001001"
      ],
      "uiLabel": ">",
      "id": "obo:GENEPIO_0001006",
      "label": "greater than"
    },
    "obo:GENEPIO_0001005": {
      "definition": "The \"greater than or equal to\" comparator indicates that a given substance was present at greater than or equal to a given quantity or concentration.",
      "member_of": [
        "obo:GENEPIO_0001001"
      ],
      "uiLabel": ">=",
      "id": "obo:GENEPIO_0001005",
      "label": "greater than or equal to"
    },
    "obo:GENEPIO_0001002": {
      "definition": "The \"less than\" comparator indicates that a given substance was present at less than a given quantity or concentration.",
      "member_of": [
        "obo:GENEPIO_0001001"
      ],
      "uiLabel": "<",
      "id": "obo:GENEPIO_0001002",
      "label": "less than"
    },
    "obo:GENEPIO_0001003": {
      "definition": "The \"less than or equal to\" comparator indicates that a given substance was present at less than or equal to a given quantity or concentration.",
      "member_of": [
        "obo:GENEPIO_0001001"
      ],
      "uiLabel": "<=",
      "id": "obo:GENEPIO_0001003",
      "label": "less than or equal to"
    },
    "obo:GENEPIO_0002049": {
      "uiLabel": "lab typing platform",
      "id": "obo:GENEPIO_0002049",
      "members": {
        "obo:GENEPIO_0002050": [],
        "obo:GENEPIO_0002051": [],
        "obo:GENEPIO_0002052": [],
        "obo:GENEPIO_0002053": [],
        "obo:GENEPIO_0002055": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:GENEPIO_0002050": {
      "uiLabel": "Microscan",
      "id": "obo:GENEPIO_0002050",
      "member_of": [
        "obo:GENEPIO_0002049"
      ]
    },
    "obo:GENEPIO_0002051": {
      "uiLabel": "Phoenix",
      "id": "obo:GENEPIO_0002051",
      "member_of": [
        "obo:GENEPIO_0002049"
      ]
    },
    "obo:GENEPIO_0002052": {
      "uiLabel": "Sensititre",
      "id": "obo:GENEPIO_0002052",
      "member_of": [
        "obo:GENEPIO_0002049"
      ]
    },
    "obo:GENEPIO_0002053": {
      "uiLabel": "Vitek",
      "id": "obo:GENEPIO_0002053",
      "member_of": [
        "obo:GENEPIO_0002049"
      ]
    },
    "obo:GENEPIO_0002055": {
      "uiLabel": "manual - noncommercial",
      "id": "obo:GENEPIO_0002055",
      "member_of": [
        "obo:GENEPIO_0002049"
      ]
    },
    "obo:GENEPIO_0002045": {
      "uiLabel": "antibiotic lab typing method",
      "id": "obo:GENEPIO_0002045",
      "members": {
        "obo:ECO_0005800": [],
        "obo:ECO_0005605": [],
        "http://www.bioassayontology.org/bao#BAO_0002146": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:ECO_0005800": {
      "definition": "A direct assay evidence where the activity of a solution is determined by exposing an indicator culture or organism to a series of dilutions and determining the lowest concentration that elicits a biological response.",
      "member_of": [
        "obo:GENEPIO_0002045"
      ],
      "uiLabel": "dilution assay evidence",
      "members": {
        "obo:GENEPIO_0002046": []
      },
      "hasExactSynonym": [
        "critical dilution assay",
        "spot assay"
      ],
      "id": "obo:ECO_0005800"
    },
    "obo:GENEPIO_0002046": {
      "uiLabel": "agar dilution evidence",
      "id": "obo:GENEPIO_0002046",
      "member_of": [
        "obo:ECO_0005800"
      ]
    },
    "obo:ECO_0005605": {
      "definition": "A type of experimental evidence where sensitivity/resistance to an antimicrobial agent is tested by impregnating small filter disks with a known concentration of antimicrobial agent which is then placed on a Mueller-Hinton agar plate inoculated with the test organism.",
      "member_of": [
        "obo:GENEPIO_0002045"
      ],
      "uiLabel": "disk diffusion test evidence",
      "hasExactSynonym": [
        "zone of inhibition evidence"
      ],
      "id": "obo:ECO_0005605"
    },
    "http://www.bioassayontology.org/bao#BAO_0002146": {
      "definition": "The lowest concentration of an inhibitor (antimicrobial agent) required to inhibit the growth of a microorganism.",
      "hasSynonym": [
        "broth dilution",
        "broth microdilution",
        "frozen broth microdilution",
        "macrodilution",
        "microbroth dilution",
        "microdilution",
        "minimal inhibitory concentration"
      ],
      "member_of": [
        "obo:GENEPIO_0002045"
      ],
      "uiLabel": "MIC",
      "id": "http://www.bioassayontology.org/bao#BAO_0002146",
      "label": "minimum inhibitory concentration"
    },
    "obo:GENEPIO_0002062": {
      "definition": "These are agency-defined standard reference methods for testing (includes quality control parameters and criteria for interpreting results)",
      "uiLabel": "antimicrobial resistance testing standard",
      "id": "obo:GENEPIO_0002062",
      "members": {
        "obo:GENEPIO_0002063": [],
        "obo:GENEPIO_0002064": [],
        "obo:GENEPIO_0002066": [],
        "obo:GENEPIO_0002065": [],
        "obo:GENEPIO_0002067": [],
        "obo:GENEPIO_0002069": [],
        "obo:GENEPIO_0002070": [],
        "obo:GENEPIO_0002068": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "obo:GENEPIO_0002063": {
      "definition": "BSAC is a British inter-professional organisation involved in antibiotic education, research and leadership",
      "member_of": [
        "obo:GENEPIO_0002062"
      ],
      "uiLabel": "BSAC",
      "id": "obo:GENEPIO_0002063",
      "label": "British Society for Antimicrobial Chemotherapy"
    },
    "obo:GENEPIO_0002064": {
      "definition": "CLSI develops and implements clinical laboratory testing standards",
      "member_of": [
        "obo:GENEPIO_0002062"
      ],
      "uiLabel": "CLSI",
      "id": "obo:GENEPIO_0002064",
      "label": "Clinical and Laboratory Standards Institute"
    },
    "obo:GENEPIO_0002066": {
      "definition": "EUCAST is a standing committee jointly organized by ESCMID, ECDC and European national breakpoint committees; it deals with breakpoints and technical aspects of phenotypic in vitro antimicrobial susceptibility testing.",
      "member_of": [
        "obo:GENEPIO_0002062"
      ],
      "uiLabel": "EUCAST",
      "id": "obo:GENEPIO_0002066",
      "label": "European Committe on Antimicrobial Susceptibility Testing"
    },
    "obo:GENEPIO_0002065": {
      "definition": "DIN is recognized by the Federal Government of Germany as the competent standards organization for Germany and as the national standards body representing Germany in non-governmental international standards organizations.",
      "member_of": [
        "obo:GENEPIO_0002062"
      ],
      "uiLabel": "Deutsches Institut f√ºr Normung",
      "id": "obo:GENEPIO_0002065",
      "label": "German Institute for Standardization (DIN)"
    },
    "obo:GENEPIO_0002067": {
      "uiLabel": "NCCLS",
      "id": "obo:GENEPIO_0002067",
      "member_of": [
        "obo:GENEPIO_0002062"
      ]
    },
    "obo:GENEPIO_0002069": {
      "uiLabel": "SIR",
      "id": "obo:GENEPIO_0002069",
      "member_of": [
        "obo:GENEPIO_0002062"
      ]
    },
    "obo:GENEPIO_0002070": {
      "uiLabel": "WRG",
      "id": "obo:GENEPIO_0002070",
      "member_of": [
        "obo:GENEPIO_0002062"
      ]
    },
    "obo:GENEPIO_0002068": {
      "definition": "The French Society of Microbiology (SFM) is a non-profit association which aims to bring together microbiologists from French-speaking countries, working in the domains of bacteria, viruses, Fungi and parasites, and related medical, industrial and environmental microbiology, physiology, genetics, taxonomy, hygiene, and antimicrobial agents.",
      "member_of": [
        "obo:GENEPIO_0002062"
      ],
      "uiLabel": "SFM",
      "id": "obo:GENEPIO_0002068",
      "label": "Soci√©t√© Fran√ßaise de Microbiologie"
    },
    "obo:GENEPIO_0002047": {
      "uiLabel": "antibiotic lab typing method version or reagent",
      "id": "obo:GENEPIO_0002047",
      "members": {
        "http://www.bioassayontology.org/bao#BAO_0000513": [],
        "obo:GENEPIO_0002060": [],
        "obo:GENEPIO_0002061": []
      },
      "member_of": [
        "obo:GENEPIO_0001655"
      ]
    },
    "http://www.bioassayontology.org/bao#BAO_0000513": {
      "uiLabel": "96 well plate",
      "id": "http://www.bioassayontology.org/bao#BAO_0000513",
      "member_of": [
        "obo:GENEPIO_0002047"
      ]
    },
    "obo:GENEPIO_0002060": {
      "uiLabel": "E-Test",
      "id": "obo:GENEPIO_0002060",
      "member_of": [
        "obo:GENEPIO_0002047"
      ]
    },
    "obo:GENEPIO_0002061": {
      "uiLabel": "GM-NEG",
      "id": "obo:GENEPIO_0002061",
      "member_of": [
        "obo:GENEPIO_0002047"
      ]
    }
  },
  "units": {
    "obo:UO_0000016": {
      "definition": "A length unit which is equal to one thousandth of a meter or 10^[-3] m.",
      "uiLabel": "millimeter",
      "id": "obo:UO_0000016",
      "label": "millimeter"
    },
    "obo:UO_0000274": {
      "definition": "A mass unit density which is equal to mass of an object in micrograms divided by the volume in millliters.",
      "uiLabel": "microgram per milliliter",
      "id": "obo:UO_0000274",
      "label": "microgram per milliliter"
    }
  }
}